ClinicalTrials.Veeva

Menu

Using Adhesive Biosensor Patches to Characterize the Biochemical Phenotype in PTSD

N

Nadav Goldental

Status

Unknown

Conditions

Post Traumatic Stress Disorder

Study type

Observational

Funder types

Other

Identifiers

NCT04071132
6381-19-SMC

Details and patient eligibility

About

A psychiatric diagnosis of post-traumatic stress disorder (PTSD) is currently based mainly on non-quantitative elements, such as interviews and subjective impressions. PTSD has physiological manifestations, some of which are likely reflected in the levels and ratios of certain stress-related proteins in the interstitial fluid and plasma. Discernable patterns of such stress-related proteins may constitute a biochemical phenotype characteristic of PTSD, which may serve as a biomarker and support diagnostic decisions, as well as personalized treatment plans.

The current study is a non-interventional observational study aimed at examining the possibility of basing a psychiatric diagnosis by measuring changes in the biochemical phenotype of participants with PTSD.

Enrollment

50 estimated patients

Sex

All

Ages

18 to 100 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • PTSD diagnosis (excluding controls)
  • Proper ability to give informed consent

Exclusion criteria

  • Active psychotic or suicidal symptoms
  • Active/terminal oncological condition
  • Dialysis patients
  • Pregnancy

Trial design

50 participants in 2 patient groups

Participants diagnosed with PTSD
Non-PTSD participants

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems